Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

• Status: Active, not recruiting
• Trial end date: 2021-11-20
• Target enrollment: 0
• Participant gender: All

Summary

To compare the efficacy and effect on glycemic control of Dulaglutide versus Liraglutide in obese Type 2 diabetic adolescents using metformin

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Corporacion Parc Tauli
• Treatments: Dulaglutide; Liraglutide

Criteria

Inclusion Criteria:

• Type 2 Diabetes Mellitus

• Obese

• Taking metformin

• Male or female

Exclusion Criteria:

• Non obese

• Not taking metformin

• Taking other injectable diabetic medications